Home
Conditions
Ovarian Cancer Stage III

Clinical trial condition

Ovarian Cancer Stage III

Explore clinical trials studying Ovarian Cancer Stage III. Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Cancer Stage III trial results

Recruiting

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT04701645

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +21 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Prehabilitation in Gynaecological Cancer Patients

NCT04789694

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations: Gynecologic Oncology Center in Prague Prague, Czechia

View Trial Details

Recruiting

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

NCT06268665

Conditions: Adnexal Diseases, Breast Cancer, Breast Cancer Invasive, +53 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

NCT04997096

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer

NCT06017557

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ginecologia Oncologica Roma, Italy

View Trial Details

Recruiting

Tumor Microenvironment in Ovarian Cancer

NCT06272240

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Università degli Studi di Udine Udine, UD, Italy

View Trial Details

Not Yet Recruiting

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

NCT05479045

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

John Theurer Cancer Center Hackensack, New Jersey, United States

View Trial Details

Completed

Self-Advocacy Serious Game in Advanced Cancer

NCT03339765

Conditions: Adnexal Diseases, Breast Cancer Stage IV, Breast Diseases, +38 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer

NCT02258165

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Royal Brisbane and Women's Hospital Herston, Queensland, Australia

Mater Health Services South Brisbane, Queensland, Australia

View Trial Details

Active, Not Recruiting

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

NCT04938583

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: Korea Anam Hospital Seoul, South Korea

Asan Medical Hospital Seoul, South Korea

Seoul St. Mary's Hospital Seoul, South Korea

Kyungpook National University Chilgok Hospital Daegu, South Korea

View Trial Details

Ovarian Cancer Stage III

Ovarian Cancer Stage III trial results

Related conditions